AstraZeneca Climbs, Philips Soars, Stellantis Falls

On this episode of Stock Movers:
- AstraZeneca shares rise as much as 2% after the drugmaker reported revenue for the second quarter that were ahead of market expectations. JPMorgan analysts called it a “high quality” sales beat.
- Philips increased its profitability outlook as the impact of the trade war was not as severe as it feared. The company now expects full-year adjusted operating earnings margin of as much as 11.8%, a 50 basis points increase from the previous outlook, according to a statement.
- Stellantis shares fall as much as 3.4% after the carmaker updated its estimate of 2025 net tariff impact to about €1.5 billion, of which €300 million was incurred in 1H25.

See omnystudio.com/listener for privacy information.